{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/SBFM",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Sunshine Biopharma Inc. (NASDAQ: SBFM) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nSunshine Biopharma Inc. is listed on NASDAQ under the ticker SBFM. The LEI is 5299005Y64EHRQDQ2Q25 and the ISIN is not on the record; several US ISINs are carried on the LEI: US8677811148, US8677811304, US8677811486, US8677815024 and US8677818093. The security type is Corporate, the segment is not on the record, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Colorado. The issuer is listed and not halted.\n\n## The disclosure read\n\nThe record holds 56 filings in the twelve months to 2026-11-08, across 41 filing days. The median gap between filing days is 5.5 days, against a NASDAQ median of 6.0 days and a sector median of 6.0 days. The latest filing is dated 2026-10-27, a regulatory filing, 12 days before the record date; the NASDAQ median latency is 5.0 days and the sector median is 4.0 days. The filings by type are 28 regulatory filings, 7 corporate news, 7 prospectus, 5 results, 5 AGM/EGM, 2 director changes and 2 directors' dealings. The NASDAQ median filing count is 52 and the sector median is 63.0.\n\n## Auditor\n\nThe auditor of record is M&K CPAS, PLLC, located in The Woodlands, TX. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed and not halted.\n\n## Orderability\n\nThe outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations pages read, and the count is 0.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's vintage is sealed, with the earliest sealed date 2021-01-04. The live record began on 2026-09-12.\n\n## Sources\n\n8 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://data.sec.gov/submissions/CIK0001402328.json (identity.jurisdiction)\n- https://api.gleif.org/api/v1/lei-records/5299005Y64EHRQDQ2Q25 (identity.lei)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/SBFM (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://www.sec.gov/Archives/edgar/data/1402328/000168316826002644/sunshine_i10k-123125.htm (the auditor)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/SBFM (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1402328/000168316826002644/sunshine_i10k-123125.htm",
    "state": "sourced",
    "value": "M&K CPAS, PLLC"
   },
   "auditor_firm_id": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1402328/000168316826002644/sunshine_i10k-123125.htm",
    "state": "sourced",
    "value": "2738"
   },
   "auditor_location": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1402328/000168316826002644/sunshine_i10k-123125.htm",
    "state": "sourced",
    "value": "The Woodlands,\nTX"
   },
   "changes": []
  },
  "cmr": "us-cm-kg/NASDAQ/SBFM",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [
    {
     "page": "https://sunshinebiopharma.com/analysts-coverage/",
     "result": "not readable by this rail (403)"
    },
    {
     "page": "https://sunshinebiopharma.com/assets/analysts%20reports/20230807%20-%20Sunshine%20Biopharma%20Initiation%20of%20Coverage.pdf?_t=1693248489",
     "result": "not readable by this rail (403)"
    },
    {
     "page": "https://sunshinebiopharma.com/wp-content/uploads/2024/08/SBFM_Analyst_Report_2024-08-20-1.pdf",
     "result": "not readable by this rail (403)"
    },
    {
     "page": "https://sunshinebiopharma.com/wp-content/uploads/2024/12/Aegis_SBFM_analyst-report_20241205.pdf",
     "result": "not readable by this rail (403)"
    },
    {
     "page": "https://sunshinebiopharma.com/wp-content/uploads/2026/04/20260408_Analyst-report.pdf",
     "result": "not readable by this rail (403)"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 526,
     "median_cadence_gap_days": 6,
     "median_filings": 63,
     "median_latency_days": 4,
     "name": "2834 Pharmaceutical Preparations"
    }
   },
   "by_type": {
    "agm_egm": 5,
    "corporate_news": 7,
    "director_change": 2,
    "directors_dealings": 2,
    "prospectus": 7,
    "regulatory_filing": 28,
    "results": 5
   },
   "cadence_median_gap_days": 5.5,
   "filing_days": 41,
   "filings": 56,
   "latency_days": 12,
   "latest": [
    {
     "category": "DEF 14C",
     "date": "2026-10-27",
     "source": "https://www.sec.gov/Archives/edgar/data/1402328/000168316826008100/sunshine_def14c.htm",
     "title": "DEF 14C — DEFINITIVE INFORMATION STATEMENT",
     "type": "regulatory_filing"
    },
    {
     "category": "SCHEDULE 13G",
     "date": "2026-10-14",
     "source": "https://www.sec.gov/Archives/edgar/data/1402328/000206334126000003/xslSCHEDULE_13G_X02/primary_doc.xml",
     "title": "SCHEDULE 13G",
     "type": "regulatory_filing"
    },
    {
     "category": "PRE 14C",
     "date": "2026-10-14",
     "source": "https://www.sec.gov/Archives/edgar/data/1402328/000168316826007847/sunshine_pre14c.htm",
     "title": "PRE 14C — PRELIMINARY INFORMATION STATEMENT",
     "type": "regulatory_filing"
    },
    {
     "category": "8-K",
     "date": "2026-10-14",
     "source": "https://www.sec.gov/Archives/edgar/data/1402328/000168316826007845/sunshine_8k.htm",
     "title": "8-K — CURRENT REPORT (items 5.07)",
     "type": "agm_egm"
    },
    {
     "category": "SCHEDULE 13G",
     "date": "2026-10-13",
     "source": "https://www.sec.gov/Archives/edgar/data/1402328/000164955326000116/xslSCHEDULE_13G_X02/primary_doc.xml",
     "title": "SCHEDULE 13G",
     "type": "regulatory_filing"
    }
   ],
   "latest_filing_date": "2026-10-27",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/SBFM",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "market": "US",
    "reason": "several US ISINs on the LEI: US8677811148, US8677811304, US8677811486, US8677815024, US8677818093",
    "state": "not_on_record"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001402328.json",
    "state": "sourced",
    "value": "United States — Colorado"
   },
   "lei": {
    "read_by": "GLEIF name-exact (jurisdiction US-CO; GLEIF golden copy 2026-09-12)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/5299005Y64EHRQDQ2Q25",
    "state": "sourced",
    "value": "5299005Y64EHRQDQ2Q25"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001402328.json",
    "state": "sourced",
    "value": "Sunshine Biopharma Inc."
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001402328.json",
    "state": "sourced",
    "value": "2834 Pharmaceutical Preparations"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001402328.json",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "SBFM"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:a72a5c22603c3de6ee9b720ed55a47db86f275db3b0d67adf4f6185b9f7b2b64",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/SBFM",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:a72a5c22603c3de6ee9b720ed55a47db86f275db3b0d67adf4f6185b9f7b2b64",
 "path": "/us/NASDAQ/SBFM",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "Sunshine Biopharma Inc. is listed on NASDAQ under the ticker SBFM. The LEI is 5299005Y64EHRQDQ2Q25 and the ISIN is not on the record; several US ISINs are carried on the LEI: US8677811148, US8677811304, US8677811486, US8677815024 and US8677818093. The security type is Corporate, the segment is not on the record, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Colorado. The issuer is listed and not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 56 filings in the twelve months to 2026-11-08, across 41 filing days. The median gap between filing days is 5.5 days, against a NASDAQ median of 6.0 days and a sector median of 6.0 days. The latest filing is dated 2026-10-27, a regulatory filing, 12 days before the record date; the NASDAQ median latency is 5.0 days and the sector median is 4.0 days. The filings by type are 28 regulatory filings, 7 corporate news, 7 prospectus, 5 results, 5 AGM/EGM, 2 director changes and 2 directors' dealings. The NASDAQ median filing count is 52 and the sector median is 63.0.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is M&K CPAS, PLLC, located in The Woodlands, TX. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed and not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations pages read, and the count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's vintage is sealed, with the earliest sealed date 2021-01-04. The live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "8 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001402328.json"
  },
  {
   "for": "identity.lei",
   "source": "https://api.gleif.org/api/v1/lei-records/5299005Y64EHRQDQ2Q25"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/SBFM"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the auditor",
   "source": "https://www.sec.gov/Archives/edgar/data/1402328/000168316826002644/sunshine_i10k-123125.htm"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/SBFM"
  }
 ],
 "title": "Sunshine Biopharma Inc. (SBFM) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}